Global Antisense Oligonucleotides Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 195888
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Antisense Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Antisense Oligonucleotides size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Antisense Oligonucleotides market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Antisense Oligonucleotides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

RNA Antisense Oligonucleotides

DNA Antisense Oligonucleotides

Market segment by Application, can be divided into

Hospitals

Clinic

Others

Market segment by players, this report covers

Ionis Pharmaceuticals

Sarepta Therapeutics

Biogen

Alnylam Pharmaceuticals

Antisense Therapeutics

Isarna Therapeutics

Arrowhead Pharmaceuticals

Atlantic Pharmaceuticals

Enzon Pharmaceuticals

Bio-Path Holdings

GlaxoSmithKline

Geron

ICO Therapeutics

Marina Biotech

RXi Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Antisense Oligonucleotides

1.2 Classification of Antisense Oligonucleotides by Type

1.2.1 Overview: Global Antisense Oligonucleotides Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Antisense Oligonucleotides Revenue Market Share by Type in 2020

1.2.3 RNA Antisense Oligonucleotides

1.2.4 DNA Antisense Oligonucleotides

1.3 Global Antisense Oligonucleotides Market by Application

1.3.1 Overview: Global Antisense Oligonucleotides Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Global Antisense Oligonucleotides Market Size & Forecast

1.5 Global Antisense Oligonucleotides Market Size and Forecast by Region

1.5.1 Global Antisense Oligonucleotides Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Antisense Oligonucleotides Market Size by Region, (2016-2021)

1.5.3 North America Antisense Oligonucleotides Market Size and Prospect (2016-2026)

1.5.4 Europe Antisense Oligonucleotides Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Antisense Oligonucleotides Market Size and Prospect (2016-2026)

1.5.6 South America Antisense Oligonucleotides Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Antisense Oligonucleotides Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Antisense Oligonucleotides Market Drivers

1.6.2 Antisense Oligonucleotides Market Restraints

1.6.3 Antisense Oligonucleotides Trends Analysis

2 Company Profiles

2.1 Ionis Pharmaceuticals

2.1.1 Ionis Pharmaceuticals Details

2.1.2 Ionis Pharmaceuticals Major Business

2.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans

2.2 Sarepta Therapeutics

2.2.1 Sarepta Therapeutics Details

2.2.2 Sarepta Therapeutics Major Business

2.2.3 Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions

2.2.4 Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Sarepta Therapeutics Recent Developments and Future Plans

2.3 Biogen

2.3.1 Biogen Details

2.3.2 Biogen Major Business

2.3.3 Biogen Antisense Oligonucleotides Product and Solutions

2.3.4 Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Biogen Recent Developments and Future Plans

2.4 Alnylam Pharmaceuticals

2.4.1 Alnylam Pharmaceuticals Details

2.4.2 Alnylam Pharmaceuticals Major Business

2.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.4.4 Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Alnylam Pharmaceuticals Recent Developments and Future Plans

2.5 Antisense Therapeutics

2.5.1 Antisense Therapeutics Details

2.5.2 Antisense Therapeutics Major Business

2.5.3 Antisense Therapeutics Antisense Oligonucleotides Product and Solutions

2.5.4 Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Antisense Therapeutics Recent Developments and Future Plans

2.6 Isarna Therapeutics

2.6.1 Isarna Therapeutics Details

2.6.2 Isarna Therapeutics Major Business

2.6.3 Isarna Therapeutics Antisense Oligonucleotides Product and Solutions

2.6.4 Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Isarna Therapeutics Recent Developments and Future Plans

2.7 Arrowhead Pharmaceuticals

2.7.1 Arrowhead Pharmaceuticals Details

2.7.2 Arrowhead Pharmaceuticals Major Business

2.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.7.4 Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans

2.8 Atlantic Pharmaceuticals

2.8.1 Atlantic Pharmaceuticals Details

2.8.2 Atlantic Pharmaceuticals Major Business

2.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.8.4 Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Atlantic Pharmaceuticals Recent Developments and Future Plans

2.9 Enzon Pharmaceuticals

2.9.1 Enzon Pharmaceuticals Details

2.9.2 Enzon Pharmaceuticals Major Business

2.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.9.4 Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Enzon Pharmaceuticals Recent Developments and Future Plans

2.10 Bio-Path Holdings

2.10.1 Bio-Path Holdings Details

2.10.2 Bio-Path Holdings Major Business

2.10.3 Bio-Path Holdings Antisense Oligonucleotides Product and Solutions

2.10.4 Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Bio-Path Holdings Recent Developments and Future Plans

2.11 GlaxoSmithKline

2.11.1 GlaxoSmithKline Details

2.11.2 GlaxoSmithKline Major Business

2.11.3 GlaxoSmithKline Antisense Oligonucleotides Product and Solutions

2.11.4 GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 GlaxoSmithKline Recent Developments and Future Plans

2.12 Geron

2.12.1 Geron Details

2.12.2 Geron Major Business

2.12.3 Geron Antisense Oligonucleotides Product and Solutions

2.12.4 Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Geron Recent Developments and Future Plans

2.13 ICO Therapeutics

2.13.1 ICO Therapeutics Details

2.13.2 ICO Therapeutics Major Business

2.13.3 ICO Therapeutics Antisense Oligonucleotides Product and Solutions

2.13.4 ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 ICO Therapeutics Recent Developments and Future Plans

2.14 Marina Biotech

2.14.1 Marina Biotech Details

2.14.2 Marina Biotech Major Business

2.14.3 Marina Biotech Antisense Oligonucleotides Product and Solutions

2.14.4 Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Marina Biotech Recent Developments and Future Plans

2.15 RXi Pharmaceuticals

2.15.1 RXi Pharmaceuticals Details

2.15.2 RXi Pharmaceuticals Major Business

2.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions

2.15.4 RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 RXi Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Antisense Oligonucleotides Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Antisense Oligonucleotides Players Market Share

3.2.2 Top 10 Antisense Oligonucleotides Players Market Share

3.2.3 Market Competition Trend

3.3 Antisense Oligonucleotides Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Antisense Oligonucleotides Revenue and Market Share by Type (2016-2021)

4.2 Global Antisense Oligonucleotides Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Antisense Oligonucleotides Revenue Market Share by Application (2016-2021)

5.2 Antisense Oligonucleotides Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Antisense Oligonucleotides Revenue by Type (2016-2026)

6.2 North America Antisense Oligonucleotides Revenue by Application (2016-2026)

6.3 North America Antisense Oligonucleotides Market Size by Country

6.3.1 North America Antisense Oligonucleotides Revenue by Country (2016-2026)

6.3.2 United States Antisense Oligonucleotides Market Size and Forecast (2016-2026)

6.3.3 Canada Antisense Oligonucleotides Market Size and Forecast (2016-2026)

6.3.4 Mexico Antisense Oligonucleotides Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Antisense Oligonucleotides Revenue by Type (2016-2026)

7.2 Europe Antisense Oligonucleotides Revenue by Application (2016-2026)

7.3 Europe Antisense Oligonucleotides Market Size by Country

7.3.1 Europe Antisense Oligonucleotides Revenue by Country (2016-2026)

7.3.2 Germany Antisense Oligonucleotides Market Size and Forecast (2016-2026)

7.3.3 France Antisense Oligonucleotides Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Antisense Oligonucleotides Market Size and Forecast (2016-2026)

7.3.5 Russia Antisense Oligonucleotides Market Size and Forecast (2016-2026)

7.3.6 Italy Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Antisense Oligonucleotides Revenue by Type (2016-2026)

8.2 Asia-Pacific Antisense Oligonucleotides Revenue by Application (2016-2026)

8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Region

8.3.1 Asia-Pacific Antisense Oligonucleotides Revenue by Region (2016-2026)

8.3.2 China Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8.3.3 Japan Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8.3.4 South Korea Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8.3.5 India Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Antisense Oligonucleotides Market Size and Forecast (2016-2026)

8.3.7 Australia Antisense Oligonucleotides Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Antisense Oligonucleotides Revenue by Type (2016-2026)

9.2 South America Antisense Oligonucleotides Revenue by Application (2016-2026)

9.3 South America Antisense Oligonucleotides Market Size by Country

9.3.1 South America Antisense Oligonucleotides Revenue by Country (2016-2026)

9.3.2 Brazil Antisense Oligonucleotides Market Size and Forecast (2016-2026)

9.3.3 Argentina Antisense Oligonucleotides Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Antisense Oligonucleotides Revenue by Type (2016-2026)

10.2 Middle East & Africa Antisense Oligonucleotides Revenue by Application (2016-2026)

10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Country

10.3.1 Middle East & Africa Antisense Oligonucleotides Revenue by Country (2016-2026)

10.3.2 Turkey Antisense Oligonucleotides Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Antisense Oligonucleotides Market Size and Forecast (2016-2026)

10.3.4 UAE Antisense Oligonucleotides Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Antisense Oligonucleotides Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Antisense Oligonucleotides Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Antisense Oligonucleotides Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Antisense Oligonucleotides Revenue (USD Million) by Region (2016-2021)

Table 5. Global Antisense Oligonucleotides Revenue Market Share by Region (2021-2026)

Table 6. Ionis Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Ionis Pharmaceuticals Major Business

Table 8. Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 9. Ionis Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors

Table 11. Sarepta Therapeutics Major Business

Table 12. Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions

Table 13. Sarepta Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Biogen Corporate Information, Head Office, and Major Competitors

Table 15. Biogen Major Business

Table 16. Biogen Antisense Oligonucleotides Product and Solutions

Table 17. Biogen Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 19. Alnylam Pharmaceuticals Major Business

Table 20. Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 21. Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Antisense Therapeutics Corporate Information, Head Office, and Major Competitors

Table 23. Antisense Therapeutics Major Business

Table 24. Antisense Therapeutics Antisense Oligonucleotides Product and Solutions

Table 25. Antisense Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Isarna Therapeutics Corporate Information, Head Office, and Major Competitors

Table 27. Isarna Therapeutics Major Business

Table 28. Isarna Therapeutics Antisense Oligonucleotides Product and Solutions

Table 29. Isarna Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Arrowhead Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Arrowhead Pharmaceuticals Major Business

Table 32. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 33. Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Atlantic Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 35. Atlantic Pharmaceuticals Major Business

Table 36. Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 37. Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Enzon Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 39. Enzon Pharmaceuticals Major Business

Table 40. Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 41. Enzon Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Bio-Path Holdings Corporate Information, Head Office, and Major Competitors

Table 43. Bio-Path Holdings Major Business

Table 44. Bio-Path Holdings Antisense Oligonucleotides Product and Solutions

Table 45. Bio-Path Holdings Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 47. GlaxoSmithKline Major Business

Table 48. GlaxoSmithKline Antisense Oligonucleotides Product and Solutions

Table 49. GlaxoSmithKline Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Geron Corporate Information, Head Office, and Major Competitors

Table 51. Geron Major Business

Table 52. Geron Antisense Oligonucleotides Product and Solutions

Table 53. Geron Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. ICO Therapeutics Corporate Information, Head Office, and Major Competitors

Table 55. ICO Therapeutics Major Business

Table 56. ICO Therapeutics Antisense Oligonucleotides Product and Solutions

Table 57. ICO Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Marina Biotech Corporate Information, Head Office, and Major Competitors

Table 59. Marina Biotech Major Business

Table 60. Marina Biotech Antisense Oligonucleotides Product and Solutions

Table 61. Marina Biotech Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. RXi Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. RXi Pharmaceuticals Major Business

Table 64. RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions

Table 65. RXi Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Antisense Oligonucleotides Revenue (USD Million) by Players (2019-2021)

Table 67. Global Antisense Oligonucleotides Revenue Share by Players (2019-2021)

Table 68. Breakdown of Antisense Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Antisense Oligonucleotides Players Head Office, Products and Services Provided

Table 70. Antisense Oligonucleotides Mergers & Acquisitions in the Past Five Years

Table 71. Antisense Oligonucleotides New Entrants and Expansion Plans

Table 72. Global Antisense Oligonucleotides Revenue (USD Million) by Type (2016-2021)

Table 73. Global Antisense Oligonucleotides Revenue Share by Type (2016-2021)

Table 74. Global Antisense Oligonucleotides Revenue Forecast by Type (2021-2026)

Table 75. Global Antisense Oligonucleotides Revenue by Application (2016-2021)

Table 76. Global Antisense Oligonucleotides Revenue Forecast by Application (2021-2026)

Table 77. North America Antisense Oligonucleotides Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Antisense Oligonucleotides Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Antisense Oligonucleotides Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Antisense Oligonucleotides Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Antisense Oligonucleotides Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Antisense Oligonucleotides Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Antisense Oligonucleotides Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Antisense Oligonucleotides Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Antisense Oligonucleotides Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Antisense Oligonucleotides Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Antisense Oligonucleotides Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Antisense Oligonucleotides Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Antisense Oligonucleotides Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Antisense Oligonucleotides Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Antisense Oligonucleotides Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Antisense Oligonucleotides Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Antisense Oligonucleotides Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Antisense Oligonucleotides Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Antisense Oligonucleotides Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Antisense Oligonucleotides Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Antisense Oligonucleotides Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Antisense Oligonucleotides Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Antisense Oligonucleotides Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Antisense Oligonucleotides Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Antisense Oligonucleotides Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Antisense Oligonucleotides Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Antisense Oligonucleotides Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Antisense Oligonucleotides Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Antisense Oligonucleotides Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Antisense Oligonucleotides Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Antisense Oligonucleotides Picture

Figure 2. Global Antisense Oligonucleotides Revenue Market Share by Type in 2020

Figure 3. RNA Antisense Oligonucleotides

Figure 4. DNA Antisense Oligonucleotides

Figure 5. Antisense Oligonucleotides Revenue Market Share by Application in 2020

Figure 6. Hospitals Picture

Figure 7. Clinic Picture

Figure 8. Others Picture

Figure 9. Global Antisense Oligonucleotides Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Antisense Oligonucleotides Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Antisense Oligonucleotides Revenue Market Share by Region (2016-2026)

Figure 12. Global Antisense Oligonucleotides Revenue Market Share by Region in 2020

Figure 13. North America Antisense Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Antisense Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Antisense Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Antisense Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Antisense Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Antisense Oligonucleotides Market Drivers

Figure 19. Antisense Oligonucleotides Market Restraints

Figure 20. Antisense Oligonucleotides Market Trends

Figure 21. Ionis Pharmaceuticals Recent Developments and Future Plans

Figure 22. Sarepta Therapeutics Recent Developments and Future Plans

Figure 23. Biogen Recent Developments and Future Plans

Figure 24. Alnylam Pharmaceuticals Recent Developments and Future Plans

Figure 25. Antisense Therapeutics Recent Developments and Future Plans

Figure 26. Isarna Therapeutics Recent Developments and Future Plans

Figure 27. Arrowhead Pharmaceuticals Recent Developments and Future Plans

Figure 28. Atlantic Pharmaceuticals Recent Developments and Future Plans

Figure 29. Enzon Pharmaceuticals Recent Developments and Future Plans

Figure 30. Bio-Path Holdings Recent Developments and Future Plans

Figure 31. GlaxoSmithKline Recent Developments and Future Plans

Figure 32. Geron Recent Developments and Future Plans

Figure 33. ICO Therapeutics Recent Developments and Future Plans

Figure 34. Marina Biotech Recent Developments and Future Plans

Figure 35. RXi Pharmaceuticals Recent Developments and Future Plans

Figure 36. Global Antisense Oligonucleotides Revenue Share by Players in 2020

Figure 37. Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Antisense Oligonucleotides Revenue Market Share in 2020

Figure 39. Global Top 10 Players Antisense Oligonucleotides Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Antisense Oligonucleotides Revenue Share by Type in 2020

Figure 42. Global Antisense Oligonucleotides Market Share Forecast by Type (2021-2026)

Figure 43. Global Antisense Oligonucleotides Revenue Share by Application in 2020

Figure 44. Global Antisense Oligonucleotides Market Share Forecast by Application (2021-2026)

Figure 45. North America Antisense Oligonucleotides Sales Market Share by Type (2016-2026)

Figure 46. North America Antisense Oligonucleotides Sales Market Share by Application (2016-2026)

Figure 47. North America Antisense Oligonucleotides Revenue Market Share by Country (2016-2026)

Figure 48. United States Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Antisense Oligonucleotides Sales Market Share by Type (2016-2026)

Figure 52. Europe Antisense Oligonucleotides Sales Market Share by Application (2016-2026)

Figure 53. Europe Antisense Oligonucleotides Revenue Market Share by Country (2016-2026)

Figure 54. Germany Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Antisense Oligonucleotides Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Antisense Oligonucleotides Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Antisense Oligonucleotides Revenue Market Share by Region (2016-2026)

Figure 62. China Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Antisense Oligonucleotides Sales Market Share by Type (2016-2026)

Figure 69. South America Antisense Oligonucleotides Sales Market Share by Application (2016-2026)

Figure 70. South America Antisense Oligonucleotides Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Antisense Oligonucleotides Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Antisense Oligonucleotides Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Antisense Oligonucleotides Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Antisense Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz